Athera Biotechnologies Ab Is A Clinical Stage Biopharmaceutical Company Based In Stockholmswedenfounded In 2002Athera Specializes In Developing Therapeutics And Diagnostics For Cardiovascular Diseasesfocusing On The Immunological Mechanisms Involved In Atherosclerosisthe Company Operates At The Intersection Of Drug Development And Companion Diagnosticsutilizing Its Expertise In Anti Inflammatory Biological Therapies Athera S Product Offerings Include Pc Maba Monoclonal Antibody Targeting Phosphorylcholineand Cvdefinea A Companion Diagnostic Kit That Measures Anti Pc Antibody Levels To Assess Cardiovascular Disease Riskthe Company Is Also Developing Additional Therapiesincluding Dianexin For Acute Coronary Syndromeathera Holds 15 Patents Related To Antibody Therapies And Diagnostic Methodsemphasizing Its Commitment To Innovation In The Field
